Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
1349.HK
Price:
$2.92
Market Cap:
$968.74M
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder, gastric, and other tumors; Trop2-BB05 ADC that is in pre-clinical studies for lung cancer and triple negative breast cancer; and HER2 ADC that has completed pre-clinical research for metastatic breast and gastric cancers. The company also provides photodynamic technical platform drugs, such as hemoporfin...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-08-13
Stock Exchange
HKSE
Ticker
1349.HK
PE Ratio
[-97.33]
ROE
[-2.74%]
Current Ratio
[8.68]
Dividend Yield
[0.59%]
Enterprise Value
[-133953293.00]
Dividend History
1349.HK Dividend History Overview
Dividends are a key part of long-term returns for investors, and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) has a track record worth reviewing. Looking at dividend history for 1349.HK gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-07-10
Dividend Yield
0.59%
Annual Dividend
$0.03
P/E Ratio
-97.33
Payout Ratio
-1.49
Dividend per Share
$0.05
EPS
-0.03
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-07-10 | $0.0321 | $0.0321 | 2025-08-25 | |
| 2024-08-26 | $0.0217 | $0.0217 | 2024-10-10 | |
| 2024-07-04 | $0.0757 | $0.0757 | 2024-08-26 | |
| 2023-06-05 | $0.0798 | $0.0798 | 2023-08-25 | |
| 2022-07-05 | $0.0859 | $0.0859 | 2022-08-26 | |
| 2021-06-01 | $0.05 | $0.05 | 2021-08-27 | |
| 2020-04-02 | $0.07 | $0.0775 | 2020-08-21 | |
| 2019-04-30 | $0.0818 | $0.0818 | 2019-08-20 | |
| 2018-06-13 | $0.0371 | $0.0371 | 2018-08-10 | |
| 2017-06-15 | $0.056 | $0.056 | 2017-08-21 | |
| 2016-05-19 | $0.0358 | $0.0358 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Dividend History Chart
The table below shows Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Dividend Growth
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 1349.HK’s dividend yield?
What is the difference between regular and special dividends?
Has 1349.HK increased its dividends over time?
Why might dividend history data be delayed?
How often does 1349.HK pay dividends?
What factors impact 1349.HK's dividend payments?
Can dividends change over time?
What is 1349.HK’s next dividend date?